Student Research Committee, Faculty of Nursing and Midwifery, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Research Center for Nursing and Midwifery Care, Department of Midwifery, School of Nursing and Midwifery, Non-Communicable Diseases Research Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Support Care Cancer. 2024 Nov 4;32(11):768. doi: 10.1007/s00520-024-08957-7.
Breast cancer and its treatments can cause sexual problems both physically and psychologically by the changes it brings. This study aimed to investigate the effect of sexual health counseling based on acceptance and commitment therapy (ACT) on the sexual satisfaction of women with chemotherapy-induced menopause (CIM) in breast cancer survivors.
Seventy women with CIM were randomly divided into two intervention (N = 34) and control (N = 36) groups. The intervention group attended eight sessions of 90-min sexual health counseling based on ACT. The control group received an educational booklet. The Sexual Satisfaction Scale for Women(SSS-W), the Sexual Quality of Life-Female questionnaire(SQOL-F), and the Menopause Rating Scale(MRS) were used to collect data before, after, and 1 month after the intervention in both groups.
The mean score of sexual satisfaction (F = 45.67, P < 0.001) and sexual quality of life (F = 33.39, P < 0.001) were significantly higher after the intervention and follow-up than before intervention in the intervention group. Also, the mean score of menopausal symptoms was significantly lower after the intervention and follow-up than before intervention in the intervention group (F = 11.80, P < 0.001). However, the mean score of sexual satisfaction (F = 0.02, P = 0.98), sexual quality of life (F = 0.05, P = 0.94), and menopausal symptoms (F = 0.08, P = 0.92) did not show significant differences before, after, and 1 month after the intervention in the control group.
Therefore, sexual health counseling based on ACT seems to have salutary effect on sexual satisfaction, sexual quality of life, and menopausal symptoms of women with breast cancer who experience CIM.
This randomized control trial has been approved by Iranian Registry of Clinical Trials, IRCT20230105057055N1 at 2023-01-29.
乳腺癌及其治疗方法会通过所带来的变化在生理和心理上导致性问题。本研究旨在探讨基于接纳与承诺疗法（ACT）的性健康咨询对乳腺癌幸存者化疗诱导绝经（CIM）女性性满意度的影响。
70 名 CIM 女性被随机分为两组，干预组（N=34）和对照组（N=36）。干预组接受 8 次 90 分钟的基于 ACT 的性健康咨询。对照组接受教育手册。在两组中，使用女性性满意度量表（SSS-W）、女性性生活质量问卷（SQOL-F）和绝经评定量表（MRS）在干预前、干预后和干预后 1 个月收集数据。
干预后和随访时，干预组的性满意度评分（F=45.67，P<0.001）和性生活质量评分（F=33.39，P<0.001）均显著高于干预前，绝经症状评分也显著低于干预前和随访时（F=11.80，P<0.001）。然而，对照组的性满意度评分（F=0.02，P=0.98）、性生活质量评分（F=0.05，P=0.94）和绝经症状评分（F=0.08，P=0.92）在干预前、干预后和随访时均无显著差异。
因此，基于 ACT 的性健康咨询似乎对经历 CIM 的乳腺癌女性的性满意度、性生活质量和绝经症状有有益的影响。
本随机对照试验已获得伊朗临床试验注册中心的批准，IRCT20230105057055N1，于 2023 年 1 月 29 日注册。
